Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comparison of unmodified and modified mRNA platforms for Andes virus mRNA vaccine in rodent models

ABSTRACT: Comparison of unmodified and modified mRNA platforms for Andes virus mRNA vaccine in rodent models Kuzmin IV, Soto-Acosta R, Pruitt L, Wasdin PT, Kedarinath K, Hernandez KR, Gonzales KA, Hill K, Weidner NG, Mire C, Engdahl TB, Moon WJ, Popov V, Crowe JE, Georgiev IS, Garcia-Blanco MA, Abbott RK, Bukreyev A. This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE240064 | GEO | 2024/07/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Andes virus mRNA vaccines: comparison of unmodified and modified mRNA platforms [VDJ-seq]

Project description:Andes virus (ANDV) is a rodent-borne zoonotic orthohantavirus endemic in South America that causes hantavirus pulmonary syndrome in humans, with up to a 40% case fatality rate. We developed ANDV mRNA vaccines based on the M segment of the viral genome that codes for glycoproteins Gn and Gc in a single open reading frame of glycoprotein precursor (GPC). We generated RNAs either with regular uridine (U-mRNA) or N1-methylpseudouridine (m1Ψ-mRNA). Mice immunized by either ANDV U-mRNA or m1Ψ-mRNA developed similar germinal center responses in lymph nodes. Single cell RNA and BCR sequencing of germinal center B cells from vaccinated mice demonstrated similar levels of activation, except an additional cluster of cells exhibiting strong interferon response that was present in animals vaccinated with U-mRNA but not m1Ψ-mRNA. Furthermore, similar immunoglobulin class-switching and somatic hypermutations were observed for the two vaccines. Golden Syrian hamsters were immunized intramuscularly with 2 doses of the vaccines on days 0 and 21. The titers of Gn/Gc-binding antibodies were moderately greater for U-mRNA construct than for m1Ψ-mRNA construct, however, the titers of ANDV-neutralizing antibodies were equivalent. Vaccinated animals were challenged with a lethal dose of ANDV at 21 days after the boost, along with the naïve control group. All control animals succumbed to infection whereas all vaccinated animals survived without any detectable disease or viral load. The data demonstrate the development of effective vaccines against ANDV and the lack of a significant effect of m1Ψ mRNA modification on immunogenicity and protection in the hamster model.

2024-07-01 | GSE240063 | GEO

Andes virus mRNA vaccines: comparison of unmodified and modified mRNA platforms [scRNA-seq]

2024-07-01 | GSE240062 | GEO

Moderate hypoxia influence at intermediate altitude in Argentinean Andes

Project description:This study evaluates genetic and phenotypic variation in the intermediate altitude Calchaquí population living in the Calchaquí Valleys of the Argentinean Andes in the town of Cachi at 2300 m. This study attempts to pinpoint evolutionary mechanisms underlying adaptation to moderate hypoxia at a intermediate altitude.

2014-04-05 | GSE56518 | GEO

Moderate hypoxia influence at intermediate altitude in Argentinean Andes

Project description:This study evaluates genetic and phenotypic variation in the intermediate altitude CalchaquÃ population living in the CalchaquÃ Valleys of the Argentinean Andes in the town of Cachi at 2300 m. This study attempts to pinpoint evolutionary mechanisms underlying adaptation to moderate hypoxia at a intermediate altitude. DNA from 24 saliva samples of CalchaquÃes living at 2300 m in Cachi in the Province of Salta in Argentina was genotyped.

2014-04-05 | E-GEOD-56518 | biostudies-arrayexpress

Andes virus mRNA vaccines: comparison of unmodified and modified mRNA platforms [VDJ-seq]

Project description:Andes virus mRNA vaccines: comparison of unmodified and modified mRNA platforms [VDJ-seq]

| PRJNA1002184 | ENA

Andes virus mRNA vaccines: comparison of unmodified and modified mRNA platforms [scRNA-seq]

Project description:Andes virus mRNA vaccines: comparison of unmodified and modified mRNA platforms [scRNA-seq]

| PRJNA1002186 | ENA

Evaluating Differential Tropism, Pathogenesis, and Antiviral Agents of Hemorrhagic Fever Renal Syndrome and Cardiopulmonary Syndrome Causative Hantaviruses: Andes virus (ANDV), Sin Nombre virus (SNV), and Hantaan virus (HTNV)

Project description:We report RNAseq analysis of control, calu3, astrocytes and cardiomyocytes cells under uninfected (mock) and Andes virus (ANDV), Sin Nombre virus (SNV), Hantaan virus (HTNV) infected and drug (synthetic 6AZA and Favipiravir, herbal Silymarin and Urolithin B) treated conditions

2024-05-16 | GSE232641 | GEO

Lobomycosis in the Tropical Andes, Bolivia, 2022

Project description:Lobomycosis in the Tropical Andes, Bolivia, 2022

| PRJEB77910 | ENA

Lobomycosis in the Tropical Andes, Bolivia, 2022

Project description:Lobomycosis in the Tropical Andes, Bolivia, 2022

| PRJEB77911 | ENA

Comparison of unmodified and modified mRNA platforms for Andes virus mRNA vaccine in rodent models

Project description:Comparison of unmodified and modified mRNA platforms for Andes virus mRNA vaccine in rodent models

| PRJNA1002143 | ENA